Stoma Care Market Summary

The global stoma care market size was estimated at USD 601.5 million in 2024 and is projected to reach USD 873.2 million by 2030, growing at a CAGR of 6.4% from 2025 to 2030. The market growth is primarily driven by rising awareness about ostomy care, increasing prevalence of chronic gastrointestinal conditions, and favorable reimbursement policies in developed regions. As healthcare systems continue to improve access to advanced stoma products, patients are becoming more open to treatment options that enhance their comfort and quality of life. Continuous innovation in product design, materials, and usability is further contributing to the market’s expansion.

Enhanced awareness and patient support programs have encouraged a larger number of individuals to seek timely treatment and adopt stoma care solutions. Favorable reimbursement structures, particularly in countries with well-established healthcare systems, have significantly improved the affordability and accessibility of essential ostomy care products. According to the CDC, the estimated prevalence of inflammatory bowel disease (IBD) in the U.S. ranges between 2.4 and 3.1 million, reflecting a substantial burden across diverse population groups. Similarly, Canada reported an IBD prevalence of 825 per 100,000 population in 2023, with 410 per 100,000 for Crohn’s disease and 414 per 100,000 for ulcerative colitis. The growing incidence of such conditions has increased the number of ostomy surgeries, directly boosting the demand for stoma care products globally.

The stoma care market in the U.S. dominated the North American region, accounting for a revenue share of 75.2% in 2024. This dominance can be attributed to advanced healthcare infrastructure, higher disease diagnosis rates, and the availability of a wide range of innovative ostomy care products. Moreover, supportive insurance coverage and government initiatives have further strengthened market growth in the country.

Key Market Trends & Insights

  • Europe dominated the global stoma care market with a revenue share of 47.2% in 2024. The region’s growth is supported by a strong presence of leading manufacturers, increasing awareness programs by healthcare organizations, and favorable reimbursement frameworks. Countries such as Germany, the U.K., and France have established comprehensive healthcare systems that ensure easy access to ostomy care supplies and patient education services.
  • The Asia Pacific stoma care market is projected to register the fastest CAGR of 6.1% during the forecast period. Rising healthcare expenditure, growing medical tourism, and increasing incidence of colorectal cancer and IBD are driving demand in emerging economies such as India, China, and Japan. The expansion of healthcare infrastructure and the introduction of cost-effective product options are expected to further accelerate regional growth.
  • Based on end-use, the home care settings segment held the largest revenue share of 46.2% in 2024. The shift toward home-based care is driven by patients’ preference for comfort, independence, and convenience, along with growing awareness about self-management of stoma care.
  • In terms of application, the colostomy segment dominated the market, accounting for a share of 44.9% in 2024. This can be attributed to the increasing prevalence of colorectal cancer and inflammatory bowel diseases, which frequently require colostomy procedures. The demand for specialized colostomy bags and accessories has also risen due to innovations that improve comfort, odor control, and ease of use.

Order a free sample PDF of the Stoma Care Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2024 Market Size: USD 601.5 Million
  • 2030 Projected Market Size: USD 873.2 Million
  • CAGR (2025-2030): 6.4%
  • Europe: Largest market in 2024
  • Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Some key companies operating in the market include ALCARE Co., Ltd.; B. Braun Medical Inc.; Coloplast Group; Cymed; ConvaTec Group PLC; Hollister Incorporated; among others. Strategic initiatives encompass mergers and acquisitions, collaborative research and development partnerships, and the launch of innovative stoma care products to enhance market competitiveness.

  • ALCARE offers the development and manufacturing of stoma care products such as ostomy bags and accessories, prioritizing patient comfort and quality with their designs, materials, and effective stoma management.
  • Coloplast provides varied ostomy products, including bags, skin barriers, and accessories. The company is recognized for its SenSura Mio line, enhancing fitness and comfort.

Key Players

  • ALCARE Co., Ltd.
  • Braun Medical Inc.
  • Coloplast Group
  • Cymed
  • ConvaTec Group PLC
  • Hollister Incorporated
  • Marlen Manufacturing & Development Company
  • Nu-Hope Laboratories, Inc.
  • Perma-Type Company, Inc.
  • Salts Healthcare
  • Welland Medical Limited
  • Torbot Group, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global stoma care market is expected to experience steady growth over the forecast period, driven by rising awareness, supportive healthcare policies, and the increasing prevalence of gastrointestinal diseases. Advancements in product design, comfort, and functionality are enhancing the quality of life for ostomy patients worldwide. The shift toward home-based care and patient-centered approaches is further broadening market adoption. As emerging economies continue to strengthen their healthcare infrastructure and accessibility, the demand for stoma care products is expected to surge. Overall, ongoing innovation and improved reimbursement systems will remain key drivers shaping the future of the global stoma care industry.